MedTrace Logo

Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients

NCT04157829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2021-04-29

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy and safety of a new medical device on the improvement of reading skills of dyslexic patients.

Conditions

  • Dyslexia

Interventions

DEVICE

Scintilling lamp

Lamp with a standardized scintilling

DEVICE

Classic lamp

Lamp without a scintilling

Sponsors & Collaborators

  • Slb Pharma

    collaborator OTHER

  • SATT Ouest Valorisation

    lead OTHER

Principal Investigators

  • Catherine Allaire, Dr · CHU Rennes

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2021-01-08
Completion
2021-01-08

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04157829 on ClinicalTrials.gov